Phytomenadione
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01022 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 67 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | renal tubular acidosis | KG + DL |
| 2 | hypophosphatemic rickets | KG + DL |
| 3 | Pendred syndrome | KG + DL |
| 4 | autosomal recessive nonsyndromic deafness | KG + DL |
| 5 | leukocyte adhesion deficiency | KG + DL |
| 6 | Fraser syndrome | KG + DL |
| 7 | temtamy preaxial brachydactyly syndrome | KG + DL |
| 8 | human HOXA1 syndromes | KG + DL |
| 9 | osteopetrosis | KG + DL |
| 10 | immune-mediated necrotizing myopathy | KG + DL |
| 11 | idiopathic eosinophilic myositis | KG + DL |
| 12 | inflammatory myopathy with abundant macrophages | KG + DL |
| 13 | antisynthetase syndrome | KG + DL |
| 14 | renal osteodystrophy | KG + DL |
| 15 | focal myositis | KG + DL |
| 16 | autosomal recessive distal hereditary motor neuropathy | KG + DL |
| 17 | calcium-alkali syndrome | KG + DL |
| 18 | primary bone dysplasia with defective bone mineralization | KG + DL |
| 19 | iron deficiency anemia | KG + DL |
| 20 | impaired renal function disease | KG + DL |
| 21 | non-renal secondary hyperparathyroidism | KG + DL |
| 22 | familial isolated hypoparathyroidism due to impaired PTH secretion | KG + DL |
| 23 | bone remodeling disease | KG + DL |
| 24 | combined oxidative phosphorylation defect | KG + DL |
| 25 | vitamin deficiency disorder | KG + DL |
| 26 | hyperparathyroidism, transient neonatal | KG + DL |
| 27 | urolithiasis | KG + DL |
| 28 | biotin metabolic disease | KG + DL |
| 29 | primary release disorder of platelets | KG + DL |
| 30 | pseudo-von Willebrand disease | KG + DL |
| 31 | acromesomelic dysplasia, Campailla Martinelli type | KG + DL |
| 32 | progressive external ophthalmoplegia | KG + DL |
| 33 | dyspepsia | KG + DL |
| 34 | Dahlberg-Borer-Newcomer syndrome | KG + DL |
| 35 | craniofacial conodysplasia | KG + DL |
| 36 | dermatomyositis | KG + DL |
| 37 | skin fragility-woolly hair-palmoplantar keratoderma syndrome | KG + DL |
| 38 | bone Paget disease | KG + DL |
| 39 | succinyl-CoA:3-ketoacid CoA transferase deficiency | KG + DL |
| 40 | autosomal recessive Alport syndrome | KG + DL |
| 41 | autosomal dominant neovascular inflammatory vitreoretinopathy | KG + DL |
| 42 | infantile osteopetrosis with neuroaxonal dysplasia | KG + DL |
| 43 | pregnancy associated osteoporosis | KG + DL |
| 44 | congenital stationary night blindness | KG + DL |
| 45 | autosomal recessive cerebellar ataxia | KG + DL |
| 46 | autosomal recessive spastic ataxia | KG + DL |
| 47 | autosomal recessive hydrocephalus due to congenital stenosis of aqueduct of Sylvius | KG + DL |
| 48 | autosomal recessive axonal hereditary motor and sensory neuropathy | KG + DL |
| 49 | obsolete vitamin D deficiency | KG + DL |
| 50 | bifid nose, autosomal recessive | KG + DL |
(Showing top 50 of 67 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.